Approval · Notice of Compliance 2608 · 2001
VALTREX: Notice of Compliance 2608
Issued August 7, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2608
- Date
- August 7, 2001
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer name
- Therapeutic class
- Antiviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VALTREX | 02219492 | Marketed |
Medicinal ingredients
- VALACYCLOVIR HYDROCHLORIDE 500 MG per TAB